神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2021 多国专家共识：帕金森病吞咽困难的治疗

2021-09-27 国外神经内科相关专家小组（统称） Journal of the Neurological Sciences

帕金森病

吞咽困难在帕金森病（PD）患者中很常见，抗PD药物对于吞咽困难的影响存在争议，本文主要针对帕金森病吞咽困难的治疗提出共识指导。

中文标题：

2021 多国专家共识：帕金森病吞咽困难的治疗

英文标题：

Consensus on the treatment of dysphagia in Parkinson's disease

发布机构：

国外神经内科相关专家小组（统称）

发布日期：

2021-09-27

简要介绍：

吞咽困难在帕金森病（PD）患者中很常见，抗PD药物对于吞咽困难的影响存在争议，本文主要针对帕金森病吞咽困难的治疗提出共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 多国专家共识：帕金森病吞咽困难的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5c08a1c00220208c, title=2021 多国专家共识：帕金森病吞咽困难的治疗, enTitle=Consensus on the treatment of dysphagia in Parkinson's disease, guiderFrom=Journal of the Neurological Sciences, authorId=0, author=, summary=吞咽困难在帕金森病（PD）患者中很常见，抗PD药物对于吞咽困难的影响存在争议，本文主要针对帕金森病吞咽困难的治疗提出共识指导。, cover=https://img.medsci.cn/20211011/1633921011506_5579292.jpg, journalId=0, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Sep 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">吞咽困难在帕金森病（PD）患者中很常见，抗PD药物对于吞咽困难的影响存在争议，本文主要针对帕金森病吞咽困难的治疗提出共识指导。</span></p>, tagList=[TagDto(tagId=337, tagName=帕金森病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=337, guiderKeyword=帕金森病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3806, appHits=175, showAppHits=0, pcHits=990, showPcHits=3630, likes=0, shares=19, comments=14, approvalStatus=1, publishedTime=Mon Oct 11 11:08:16 CST 2021, publishedTimeString=2021-09-27, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Oct 11 10:58:58 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:41:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 多国专家共识：帕金森病吞咽困难的治疗.pdf)])
2021 多国专家共识：帕金森病吞咽困难的治疗.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1074730, encodeId=279b10e4730d3, content=最新的指南，紧跟前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70161608917, createdName=lrq0424, createdTime=Sun Nov 28 11:07:30 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062327, encodeId=35d6106232e73, content=学习了，新的指南，值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0d5511730, createdName=一一人, createdTime=Wed Oct 20 18:46:47 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061648, encodeId=8c2e1061648e4, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Oct 18 23:54:34 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059773, encodeId=eee41059e736c, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91115623607, createdName=ms7000001501087764, createdTime=Tue Oct 12 14:08:20 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059546, encodeId=4a211059546de, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32105578124, createdName=ms5000001907101041, createdTime=Mon Oct 11 18:59:00 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-11-28 lrq0424

    最新的指南，紧跟前沿

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1074730, encodeId=279b10e4730d3, content=最新的指南，紧跟前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70161608917, createdName=lrq0424, createdTime=Sun Nov 28 11:07:30 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062327, encodeId=35d6106232e73, content=学习了，新的指南，值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0d5511730, createdName=一一人, createdTime=Wed Oct 20 18:46:47 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061648, encodeId=8c2e1061648e4, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Oct 18 23:54:34 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059773, encodeId=eee41059e736c, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91115623607, createdName=ms7000001501087764, createdTime=Tue Oct 12 14:08:20 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059546, encodeId=4a211059546de, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32105578124, createdName=ms5000001907101041, createdTime=Mon Oct 11 18:59:00 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-20 一一人

    学习了，新的指南，值得探讨

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1074730, encodeId=279b10e4730d3, content=最新的指南，紧跟前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70161608917, createdName=lrq0424, createdTime=Sun Nov 28 11:07:30 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062327, encodeId=35d6106232e73, content=学习了，新的指南，值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0d5511730, createdName=一一人, createdTime=Wed Oct 20 18:46:47 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061648, encodeId=8c2e1061648e4, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Oct 18 23:54:34 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059773, encodeId=eee41059e736c, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91115623607, createdName=ms7000001501087764, createdTime=Tue Oct 12 14:08:20 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059546, encodeId=4a211059546de, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32105578124, createdName=ms5000001907101041, createdTime=Mon Oct 11 18:59:00 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-18 ms6000001387765207

    学习了学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1074730, encodeId=279b10e4730d3, content=最新的指南，紧跟前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70161608917, createdName=lrq0424, createdTime=Sun Nov 28 11:07:30 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062327, encodeId=35d6106232e73, content=学习了，新的指南，值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0d5511730, createdName=一一人, createdTime=Wed Oct 20 18:46:47 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061648, encodeId=8c2e1061648e4, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Oct 18 23:54:34 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059773, encodeId=eee41059e736c, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91115623607, createdName=ms7000001501087764, createdTime=Tue Oct 12 14:08:20 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059546, encodeId=4a211059546de, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32105578124, createdName=ms5000001907101041, createdTime=Mon Oct 11 18:59:00 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-12 ms7000001501087764

    挺好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1074730, encodeId=279b10e4730d3, content=最新的指南，紧跟前沿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70161608917, createdName=lrq0424, createdTime=Sun Nov 28 11:07:30 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062327, encodeId=35d6106232e73, content=学习了，新的指南，值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0d5511730, createdName=一一人, createdTime=Wed Oct 20 18:46:47 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061648, encodeId=8c2e1061648e4, content=学习了学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Oct 18 23:54:34 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059773, encodeId=eee41059e736c, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91115623607, createdName=ms7000001501087764, createdTime=Tue Oct 12 14:08:20 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059546, encodeId=4a211059546de, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32105578124, createdName=ms5000001907101041, createdTime=Mon Oct 11 18:59:00 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-11 ms5000001907101041

    很实用

    0

相关指南

帕金森病痴呆的诊断标准与治疗指南(第二版)

中华医学会神经病学分会帕金森病及运动障碍学组 · 2021-08-08

中国帕金森病轻度认知障碍的诊断和治疗指南(2020 版)

中华医学会神经病学分会帕金森病及运动障碍学组 · 2021-01-27

中国帕金森病早期运动症状治疗循证医学指南

中华医学会神经病学分会帕金森病及运动障碍学组 · 2021-07-15

帕金森病睡眠障碍中西医结合管理专家共识( 2021)

暂未更新 · 2021-05-30

帕金森病自主神经功能障碍中西医结合诊治专家共识 （2020）

中国神经内科相关专家小组（统称） · 2021-01-13

中国帕金森病治疗指南（第四版）

中华医学会神经病学分会帕金森病及运动障碍学组 · 2020-12-21

拓展阅读

2015 ICS指南：帕金森病和其他步态障碍性疾病膀胱功能障碍的管理

国际尿控协会(ICS,International Continence Society) · 2015-03-25

中国帕金森病的诊断标准（2016版）

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-11

2016 中国帕金森病及运动障碍疾病临床大数据库建设专家共识

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-30

帕金森病脑深部电刺激疗法术后程控中国专家共识

中华医学会神经外科学分会 · 2016-12-30

2016中国帕金森病诊断标准解读

暂未更新 · 2017-04-06

帕金森病康复中国专家共识

中华医学会神经病学分会神经康复学组 · 2018-04-15